Literature DB >> 30886048

A protein quality control pathway regulated by linear ubiquitination.

Eva M van Well1, Verian Bader1, Maria Patra2, Ana Sánchez-Vicente1, Jens Meschede1, Nikolas Furthmann1, Cathrin Schnack1, Alina Blusch3, Joseph Longworth4, Elisabeth Petrasch-Parwez5, Kohji Mori6, Thomas Arzberger7,8,9, Dietrich Trümbach10, Lena Angersbach1, Cathrin Showkat1, Dominik A Sehr1, Lena A Berlemann1, Petra Goldmann1, Albrecht M Clement11, Christian Behl11, Andreas C Woerner12, Carsten Saft3, Wolfgang Wurst9,10,13,14, Christian Haass6,9,14, Gisa Ellrichmann3, Ralf Gold3, Gunnar Dittmar4, Mark S Hipp12,14, F Ulrich Hartl12,14, Jörg Tatzelt2,15,16, Konstanze F Winklhofer17,2,9,14,16.   

Abstract

Neurodegenerative diseases are characterized by the accumulation of misfolded proteins in the brain. Insights into protein quality control mechanisms to prevent neuronal dysfunction and cell death are crucial in developing causal therapies. Here, we report that various disease-associated protein aggregates are modified by the linear ubiquitin chain assembly complex (LUBAC). HOIP, the catalytic component of LUBAC, is recruited to misfolded Huntingtin in a p97/VCP-dependent manner, resulting in the assembly of linear polyubiquitin. As a consequence, the interactive surface of misfolded Huntingtin species is shielded from unwanted interactions, for example with the low complexity sequence domain-containing transcription factor Sp1, and proteasomal degradation of misfolded Huntingtin is facilitated. Notably, all three core LUBAC components are transcriptionally regulated by Sp1, linking defective LUBAC expression to Huntington's disease. In support of a protective activity of linear ubiquitination, silencing of OTULIN, a deubiquitinase with unique specificity for linear polyubiquitin, decreases proteotoxicity, whereas silencing of HOIP has the opposite effect. These findings identify linear ubiquitination as a protein quality control mechanism and hence a novel target for disease-modifying strategies in proteinopathies.
© 2019 The Authors.

Entities:  

Keywords:  zzm321990LUBACzzm321990; zzm321990OTULINzzm321990; Huntingtin; p97; protein aggregation

Mesh:

Substances:

Year:  2019        PMID: 30886048      PMCID: PMC6484417          DOI: 10.15252/embj.2018100730

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  66 in total

1.  Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.

Authors:  Anthone W Dunah; Hyunkyung Jeong; April Griffin; Yong-Man Kim; David G Standaert; Steven M Hersch; M Maral Mouradian; Anne B Young; Naoko Tanese; Dimitri Krainc
Journal:  Science       Date:  2002-05-02       Impact factor: 47.728

2.  Differential proteomic analysis of mouse macrophages exposed to adsorbate-loaded heavy fuel oil derived combustion particles using an automated sample-preparation workflow.

Authors:  Tamara Kanashova; Oliver Popp; Jürgen Orasche; Erwin Karg; Horst Harndorf; Benjamin Stengel; Martin Sklorz; Thorsten Streibel; Ralf Zimmermann; Gunnar Dittmar
Journal:  Anal Bioanal Chem       Date:  2015-03-14       Impact factor: 4.142

3.  Structural basis for recognition of diubiquitins by NEMO.

Authors:  Yu-Chih Lo; Su-Chang Lin; Carla C Rospigliosi; Dietrich B Conze; Chuan-Jin Wu; Jonathan D Ashwell; David Eliezer; Hao Wu
Journal:  Mol Cell       Date:  2009-01-29       Impact factor: 17.970

4.  Global changes to the ubiquitin system in Huntington's disease.

Authors:  Eric J Bennett; Thomas A Shaler; Ben Woodman; Kwon-Yul Ryu; Tatiana S Zaitseva; Christopher H Becker; Gillian P Bates; Howard Schulman; Ron R Kopito
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

5.  Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A.

Authors:  Kavita P Bhat; Sen Yan; Chuan-En Wang; Shihua Li; Xiao-Jiang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

6.  Effects of mutations and deletions in the human optineurin gene.

Authors:  Sanja Turturro; Xiang Shen; Rajalekshmy Shyam; Beatrice Yjt Yue; Hongyu Ying
Journal:  Springerplus       Date:  2014-02-19

7.  LUBAC synthesizes linear ubiquitin chains via a thioester intermediate.

Authors:  Benjamin Stieglitz; Aylin C Morris-Davies; Marios G Koliopoulos; Evangelos Christodoulou; Katrin Rittinger
Journal:  EMBO Rep       Date:  2012-07-13       Impact factor: 8.807

8.  Structural basis for ligase-specific conjugation of linear ubiquitin chains by HOIP.

Authors:  Benjamin Stieglitz; Rohini R Rana; Marios G Koliopoulos; Aylin C Morris-Davies; Veronique Schaeffer; Evangelos Christodoulou; Steven Howell; Nicholas R Brown; Ivan Dikic; Katrin Rittinger
Journal:  Nature       Date:  2013-10-20       Impact factor: 49.962

Review 9.  Ubiquitin modifications.

Authors:  Kirby N Swatek; David Komander
Journal:  Cell Res       Date:  2016-03-25       Impact factor: 25.617

10.  The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis.

Authors:  Elena Rivkin; Stephanie M Almeida; Derek F Ceccarelli; Yu-Chi Juang; Teresa A MacLean; Tharan Srikumar; Hao Huang; Wade H Dunham; Ryutaro Fukumura; Gang Xie; Yoichi Gondo; Brian Raught; Anne-Claude Gingras; Frank Sicheri; Sabine P Cordes
Journal:  Nature       Date:  2013-05-24       Impact factor: 49.962

View more
  20 in total

1.  Lining up for quality control: linear ubiquitin and proteotoxicity.

Authors:  R Luke Wiseman
Journal:  EMBO J       Date:  2019-04-11       Impact factor: 11.598

Review 2.  Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities.

Authors:  Sarah J Tabrizi; Carlos Estevez-Fraga; Willeke M C van Roon-Mom; Michael D Flower; Rachael I Scahill; Edward J Wild; Ignacio Muñoz-Sanjuan; Cristina Sampaio; Anne E Rosser; Blair R Leavitt
Journal:  Lancet Neurol       Date:  2022-07       Impact factor: 59.935

3.  The p97-UBXN1 complex regulates aggresome formation.

Authors:  Sirisha Mukkavalli; Jacob Aaron Klickstein; Betty Ortiz; Peter Juo; Malavika Raman
Journal:  J Cell Sci       Date:  2021-04-15       Impact factor: 5.285

Review 4.  Dicarbonyl stress, protein glycation and the unfolded protein response.

Authors:  Naila Rabbani; Mingzhan Xue; Paul J Thornalley
Journal:  Glycoconj J       Date:  2021-03-01       Impact factor: 2.916

Review 5.  Met1-linked ubiquitin signalling in health and disease: inflammation, immunity, cancer, and beyond.

Authors:  Akhee Sabiha Jahan; Camilla Reiter Elbæk; Rune Busk Damgaard
Journal:  Cell Death Differ       Date:  2021-01-13       Impact factor: 12.067

Review 6.  Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders.

Authors:  Daisuke Oikawa; Yusuke Sato; Hidefumi Ito; Fuminori Tokunaga
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

Review 7.  Strategies to Investigate Ubiquitination in Huntington's Disease.

Authors:  Karen A Sap; Eric A Reits
Journal:  Front Chem       Date:  2020-06-11       Impact factor: 5.221

Review 8.  How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review.

Authors:  Beata Lontay; Andrea Kiss; László Virág; Krisztina Tar
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

Review 9.  HOIL-1, an atypical E3 ligase that controls MyD88 signalling by forming ester bonds between ubiquitin and components of the Myddosome.

Authors:  Philip Cohen; Ian R Kelsall; Sambit K Nanda; Jiazhen Zhang
Journal:  Adv Biol Regul       Date:  2019-10-05

10.  Differential Diagnosis of Chorea-HIV Infection Delays Diagnosis of Huntington's Disease by Years.

Authors:  Jannis Achenbach; Simon Faissner; Carsten Saft
Journal:  Brain Sci       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.